Latest Options News

Panther Metals has announced a maiden JORC Mineral Resource Estimate for its Burtville East Gold Project, revealing promising high-grade gold grades and initiating a scoping study to explore open pit mining viability.

Clime Investment Management has bolstered its balance sheet with a $2.3 million placement and launched a strategic product review amid evolving market dynamics and industry consolidation.

PVW Resources has advanced its Brazilian rare earth projects with promising drilling and metallurgical results, while securing a strategic acquisition of gold and silver assets in the US to diversify its portfolio.

Renascor Resources has commenced construction of its government-backed Purified Spherical Graphite demonstration plant in Adelaide, while securing key land and expanding exploration amid shifting global graphite supply dynamics.

Venari Minerals has launched RC drilling at its Red Mountain Lithium Project aiming for a maiden resource by year-end, while Needles Gold Project drilling confirms promising gold-silver targets. A $5.5 million placement strengthens its exploration funding.

Beacon Minerals reported solid gold production of 6,884 ounces in Q3 2025 with a strategic focus on expanding its Iguana deposit and maintaining a robust gold retention strategy.

Jameson Resources has made significant strides in advancing its Crown Mountain Hard Coking Coal Project, progressing environmental assessments and Indigenous partnerships while securing fresh capital to support development.

Basin Energy has acquired NeoDys Limited, gaining a substantial uranium and rare earth exploration package in Queensland, and launched a $1.25 million capital raise to fund maiden drilling in late 2025.

Galilee Energy reported steady cash reserves and ongoing reservoir pressure monitoring at its Glenaras Gas Project, while exploring new funding and growth opportunities.

Hastings Technology Metals and Wyloo have signed a non-binding agreement with Ucore Rare Metals to negotiate a long-term offtake for rare earth concentrate and explore US-based downstream processing.

Simble Solutions reports new multi-year contracts in the UK and Australia, boosting revenue prospects, but faces a cash runway of less than one quarter and is exploring funding options.

Imugene Limited reports an 81% overall response rate in its azer-cel CAR T-cell therapy trial for difficult lymphomas, alongside a $25 million capital raise that extends its cash runway to mid-2027.